ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest novartis news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks novartis across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.

Novartis is acquiring a U.K. cancer drug startup for up to $1.5 billion. The deal includes an upfront payment and additional milestone-based payments. The acquisition expands Novartis's oncology pipeline with the startup's early-stage therapies.
Summaries by ByteBrief